Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies [Phase 1, Phase 2]
A dose-finding and safety study of an oral single-agent therapy for advanced solid tumors, including metastatic bladder cancer, completed wi…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions [Phase 2]
Phase 2 trial evaluating topical tazarotene vs placebo for hand-foot skin reactions in solid tumor patients; study terminated with results p…
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents [Phase 1, Phase 2]
Phase 1/2 trial evaluating OR2805, a anti-CD163 monoclonal antibody, alone and with anticancer agents for solid tumors, with unspecified sta…
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28) [Phase 1]
Phase 1 study of pembrolizumab in participants with advanced solid tumors has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X) [NA]
Completed clinical trial evaluating performance and safety of biology-guided radiotherapy with the RefleXion Radiotherapy System (BIOGUIDE-X…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: A Study of HB0045 Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A phase 1/2 clinical trial update for HB0045 Injection in adults with solid tumors is ongoing, with current status not disclosed.
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors [Phase 2]
Phase 2 trial update on pembrolizumab activity in tumors with homologous recombination competency status, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors [Phase 1]
Phase 1 results for a study combining the TORC1/2 inhibitor MLN0128 (sapanisertib) with bevacizumab in adults with recurrent glioblastoma or…
-
CLINICAL_TRIALS trial_result · 2023-10-02Clinical Trial Update: A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes [Phase 2]
Phase 2 study evaluating rucaparib in participants with solid tumors and deleterious HRR gene mutations; study terminated with posted result…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: IMX-110 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for IMX-110 in adults with advanced solid tumors across Phase 1 and Phase 2 is listed, with multiple solid tumor ind…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor [Phase 2]
Phase 2 trial evaluating camrelizumab and famitinib in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update reporting a Phase 1/2 study of QLS31905 in combination chemotherapy as first-line treatment for advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for 7MW3711 in advanced solid tumors is reported, with status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Study of 7MW3711 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for 7MW3711 in subjects with advanced solid tumors (Phase 1/Phase 2) with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors [Phase 2]
Phase 2 clinical trial update for pemigatinib in solid tumors with FGF/FGFR alterations; status and conditions are reported but final result…
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors [Phase 1]
Phase 1 study of HS130 in combination with Viagenpumatucel-L (HS110) in patients with advanced solid tumors has been completed with results …
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: AO-176 in Multiple Solid Tumor Malignancies [Phase 1, Phase 2]
Phase 1/2 trial update for AO-176 in solid tumor malignancies completed.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers [Phase 2]
Phase 2 clinical trial update for a MUC1 therapeutic tumor vaccine in adults with solid tumors.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
An early-phase study evaluating IMX-110 in combination with tislelizumab in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation [Phase 1, Phase 2]
Phase I/II clinical trial update for YL-15293 in patients with advanced solid tumors harboring KRAS mutations.
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: M6620 (VX-970) in Selected Solid Tumors [Phase 2]
Phase 2 trial of M6620 (VX-970) in selected solid tumors completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: ALG.APV-527 First-in-human Study [Phase 1, Phase 2]
First-in-human study update for ALG.APV-527 investigating solid tumors in Phase 1/Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors [Phase 1, Phase 2]
Early-stage trial updating on combining stereotactic body radiotherapy with cadonilimab for advanced solid tumors, across Phase 1 and Phase …
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for JBI-802, an LSD1/HDAC6 inhibitor, in locally advanced or metastatic solid tumors. No current status avai…